Chromoblastomycosis after a leech bite complicated by myiasis: a case report
© Slesak et al; licensee BioMed Central Ltd. 2011
Received: 2 August 2010
Accepted: 12 January 2011
Published: 12 January 2011
Chromoblastomycosis is a chronic mycotic infection, most common in the tropics and subtropics, following traumatic fungal implantation.
A 72 year-old farmer was admitted to Luang Namtha Provincial Hospital, northern Laos, with a growth on the left lower leg which began 1 week after a forefoot leech bite 10 years previously. He presented with a cauliflower-like mass and plaque-like lesions on his lower leg/foot and cellulitis with a purulent tender swelling of his left heel. Twenty-two Chrysomya bezziana larvae were extracted from his heel. PCR of a biopsy of a left lower leg nodule demonstrated Fonsecaea pedrosoi, monophora, or F. nubica. He was successfully treated with long term terbinafin plus itraconazole pulse-therapy and local debridement.
Chromoblastomycosis is reported for the first time from Laos. It carries the danger of bacterial and myiasis superinfection. Leech bites may facilitate infection.
Chromoblastomycosis is a worldwide chronic infection of the skin and subcutaneous tissue, most commonly found in tropical and subtropical areas. It is mainly caused by the fungal genera Fonsecaea, Phialophora and Cladophialophora that are saprophytes in soil and plants [1–3]. Fonsecaea pedrosoi is the commonest agent found in tropical rain forests . Infection occurs by traumatic cutaneous implantation of fungi , for example by skin abrasion from wood or thorns and rarely by an insect or leech bite [4, 5]. The lower limbs are most commonly infected and the nodular and/or verrucous plaques can develop centripetal satellite lesions. The most frequent complication is bacterial secondary infection, but malignancies have also been recorded [1, 2, 6]. Diagnosis can be made by direct microscopic demonstration of pathognomonic brown sclerotic cells (also called fumagoid or muriform cells) in skin scrapings [1–3].
Additional file 1: Videoclip showing perpendicular scraping movements of maggots in the patient's very tender heel that initially were overlooked. (WMV 1 MB)
In order to confirm the diagnosis, and as fungal cultures were not available in Laos, identification by PCR was attempted at Tübingen from heated and ethanol-treated tissue. DNA extraction was performed from each of three tissue samples of about 3 mm in diameter from the patient's lower leg. Fungal DNA was amplified with two different PCR-protocols, using primers of the internal transcribed spacer (ITS) 1 and 4 region [9, 10] and the conserved 18S subunit of the rRNA gene  with 2.5 μl of DNA-extract applied in each PCR reaction. PCR-products were subsequently sequenced as described  and compared with Basic Local Alignment Search Tool (BLAST). PCR using ITS primers remained negative in all 3 samples, whereas 18S rRNA-PCR was positive in one of the 3 samples. Subsequent sequencing revealed 100% similarity with Fonsecaea pedrosoi, monophora, and F. nubica. The sequence was published in GenBank (accession number HQ616145).
Chromoblastomycosis has been reported from neighbouring Thailand and China [5, 12], and it is likely to be endemic in Laos. Its slow growth and variable appearance may result in confusion with skin cancer, eczema, psoriasis, or leprosy, as in our patient. Direct microscopic identification of muriform/sclerotic cells is diagnostic [1–3] but doctors have to be aware of this differential diagnosis. Treatment remains challenging, especially in financially-poor countries. Antifungals needed to be given for at least 6-12 months, often combined with physical treatments such as surgery, cryotherapy and thermotherapy. Cure rates range from 15% to 80% . Despite being the most common aetiological agent, F. pedrosoi appears to be less sensitive to antifungal therapy than either C. carrionii or P. verrucosa [1, 2]. However, terbinafin has shown high tolerability and efficacy especially against F. pedrosoi, even in imidazole-refractory cases  and dual therapy with itraconazole and terbinafin is recommended . Which species of Fonsecaea was responsible remains unclear in our patient. The gene sequence analysis using 18S primers, in contrast to ITS primers, which have been used for Fonsecaea species identification in pure cultures [14–16], cannot distinguish between Fonsecaea pedrosoi, F. monophora and F. nubica . The finding that only one sample was positive with 18S primers might be due to a very low fungal load or an alteration during the sample processing and transport from remote northern Laos. PCR with 18S primers may have a higher sensitivity for the detection of Fonsecaea spp. from biopsy material compared to ITS primers, however, PCR diagnosis of Fonsecaea spp. is not yet standardized.
It is possible that the patient acquired the infection via the leech bite or subsequently through the wound. The injection of platelet inhibitors during leech bites  might impair the local skin immunity increasing the risk for fungal infections. The coagulation system overlaps with the immune system and many acute-phase proteins of inflammation are also involved in the coagulation process. Platelet microbiocidal proteins and konocidins have shown to exert strong efficacy against bacteria and fungi . To our knowledge this is the second report of chromoblastomycosis associated with a leech bite . Since leeches are typically found in humid tropical areas, as is chromoblastomycosis, there might be an important but overlooked association. Leech bites have been associated with Aeromonas hydrophilia infections, complicating 2.4% to 20% of medical leech therapies , but might also be involved in the pathogenesis of other tropical soil-related infections, such as Chromobacterium violaceum septicaemia . Ingested blood in leeches' digestive tract can contain various pathogens, including HIV and hepatitis B, that, although unproven, could be re-injected into another host by regurgitation during the manipulation of leech removal .
Bacterial superinfection is a relatively common complication of chromoblastomycosis [1, 2] but myiasis does not appear to have been reported. Cochliomyia hominivorax, Chrysomya bezziana, and Wohlfahrtia magnifica are the most common flies worldwide causing human wound myiasis. Chrysomya bezziana is the most common cause in India and Southeast Asia . Although scientific evidence from Laos is scarce, old clinical descriptions indicate that myiasis has been a common poverty-related complication of neglected wounds in remote areas of Laos . Massive tissue destruction, bone erosion, and death can occur from infestation by Old World screwworm larvae . Our patient had only three of the reported predisposing factors for wound myiasis including advanced age, poor social condition and hygiene, but did not have diabetes, vascular occlusive disease, alcoholism, mental/psychiatric illness, or physical disability . However, the skin lesions of chromoblastomycosis could facilitate fly eggs deposition and might represent another risk factor for human wound myiasis. Although a potentially serious complication, the larval infestation and associated pain had the benefit here of prompting our patient to seek medical attention, which led to the root cause of his ten-year condition being successfully diagnosed and treated.
Chromoblastomycosis is reported for the first time from Laos and should be considered in the differential diagnosis of chronic skin diseases. Leech bites might facilitate infection and bacterial superinfection and myiasis may occur.
Written informed consent was obtained from the patient for publication of this case report including pictures and video.
We thank the NGO SFE for the financial and organizational support of the patient's treatment and follow-up, and the Wellcome Trust of Great Britain for support of the microbiology testing and specimen transport. We are very grateful to Stephanie Richt and Mariola Gwozdz (Interfakultäres Institut für Mikrobiologie und Infektionsmedizin Tübingen, Germany) who performed the fungal PCR with subsequent sequence analysis, the NGO Direct Relief International, especially Matt MacCalla, for the rapid assistance in obtaining terbinafin, Dr Rattanaphone Phetsouvanh and Dr Mayfong Mayxay and all staff of the Microbiology Laboratory, Mahosot Hospital and Cheryl Whitehorn of the London School of Hygiene and Tropical Medicine for assistance. PNN is supported by Wellcome Trust of Great Britain.
- Ameen M: Chromoblastomycosis: clinical presentation and management. Clin Exp Dermatol. 2009, 34: 849-854. 10.1111/j.1365-2230.2009.03415.x.View ArticlePubMedGoogle Scholar
- Bonifaz A, Carrasco-Gerard E, Saúl A: Chromoblastomycosis: clinical and mycologic experience of 51 cases. Mycoses. 2001, 44: 1-7. 10.1046/j.1439-0507.2001.00613.x.View ArticlePubMedGoogle Scholar
- Queiroz-Telles F, Esterre P, Perez-Blanco M, Vitale RG, Salgado CG, Bonifaz A: Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment. Med Mycol. 2009, 47: 3-15. 10.1080/13693780802538001.View ArticlePubMedGoogle Scholar
- Sauerteig E, Hernández R, Salfelder K, Bastidas C: Acute chromoblastomycosis provoked by an insect bite in an immunosuppressed patient. Mycoses. 1998, 41: 191-194. 10.1111/j.1439-0507.1998.tb00322.x.View ArticlePubMedGoogle Scholar
- Ungpakorn R, Reangchainam S: Pulse itraconazole 400 mg daily in the treatment of chromoblastomycosis. Clin Exp Dermatol. 2006, 31: 245-247. 10.1111/j.1365-2230.2005.02024.x.View ArticlePubMedGoogle Scholar
- Minotto R, Bernardi CDV, Mallmann LF, Edelweiss MIA, Scroferneker ML: Chromoblastomycosis: a review of 100 cases in the state of Rio Grande do Sul, Brazil. J Am Acad Dermatol. 2001, 44: 585-592. 10.1067/mjd.2001.112220.View ArticlePubMedGoogle Scholar
- Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard. . 2009, Wayne, PA: Clinical and Laboratory Standards Institute, Approved Standard M02-A10., TenthGoogle Scholar
- Hall MJR: New World screwworm (Cochliomyia hominivorax) and Old World screwworm (Chrysomya bezziana). Manual of Diagnostic Tests and Vaccines for Terrestrial Animals (mammals, birds and bees). 2008, OiE, World Organisation for Animal Health. Paris, France, 1: 265-275. Chapter 2.1.10, [http://www.oie.int/eng/Normes/mmanual/2008/pdf/2.01.10_SCREWW.pdf]SixthGoogle Scholar
- Loeffler J, Hebart H, Bialek R, Hagmeyer L, Schmidt D, Serey FP, Hartmann M, Eucker J, Einsele H: Contaminations occurring in fungal PCR assays. J Clin Microbiol. 1999, 37: 1200-1202.PubMedPubMed CentralGoogle Scholar
- Leinberger DM, Schumacher U, Autenrieth IB, Bachmann TT: Development of a DNA microarray for detection and identification of fungal pathogens involved in invasive mycoses. J Clin Microbiol. 2005, 43: 4943-53. 10.1128/JCM.43.10.4943-4953.2005.View ArticlePubMedPubMed CentralGoogle Scholar
- Einsele H, Hebart H, Roller G, Löffler J, Rothenhöfer I, Müller CA, Bowden RA, Van Burik JA, Engelhard D, Kanz L, Schumacher U: Detection and identification of fungal pathogens in blood by using molecular probes. J Clin Microbiol. 1997, 35: 1353-60.PubMedPubMed CentralGoogle Scholar
- Zhang J, Xi L, Lu C, Li X, Xie T, Zhang H, Xie Z, Sybren DH: Successful treatment for chromoblastomycosis caused by Fonsecaea monophora: a report of three cases in Guangdong, China. Mycoses. 2008, 52: 176-181. 10.1111/j.1439-0507.2008.01547.x.View ArticlePubMedGoogle Scholar
- Esterre P, Inzan CK, Ramarcel ER, Andriantsimahavandy A, Ratsioharana M, Pecarrere JL, Roig P: Treatment of chromomycosis with terbinafine: preliminary results of an open pilot study. Br J Dermatol. 1996, 134 (Suppl 46): 33-36. 10.1111/j.1365-2133.1996.tb15658.x.View ArticlePubMedGoogle Scholar
- Xi L, Sun J, Lu C, Liu H, Xie Z, Fukushima K, Takizawa K, Najafzadeh MJ, De Hoog GS: Molecular diversity of Fonsecaea (Chaetothyriales) causing chromoblastomycosis in southern China. Med Mycol. 2009, 47: 27-33. 10.1080/13693780802468209.View ArticlePubMedGoogle Scholar
- De Andrade TS, Cury AE, de Castro LG, Hirata MH, Hirata RD: Rapid identification of Fonsecaea by duplex polymerase chain reaction in isolates from patients with chromoblastomycosis. Diagn Microbiol Infect Dis. 2007, 57: 267-272. 10.1016/j.diagmicrobio.2006.08.024.View ArticlePubMedGoogle Scholar
- Sun J, Najafzadeh MJ, Vicente V, Xi L, de Hoog GS: Rapid detection of pathogenic fungi using loop-mediated isothermal amplification, exemplified by Fonsecaea agents of chromoblastomycosis. J Microbiol Methods. 2010, 80: 19-24. 10.1016/j.mimet.2009.10.002.View ArticlePubMedGoogle Scholar
- Najafzadeh MJ, Sun J, Vicente V, Xi L, van den Ende AH, de Hoog GS: Fonsecaea nubica sp. nov a new agent of human chromoblastomycosis revealed using molecular data. Med Mycol. 2010, 48: 800-6. 10.3109/13693780903503081.View ArticlePubMedGoogle Scholar
- White TC, Berny MA, Robinson DK, Yin H, DeGrado WF, Hanson SR, McCarty OJT: The leech product saratin is a potent inhibitor of platelet integrin α2β1 and von Willebrand factor binding to collagen. FEBS J. 2007, 274: 1481-1491. 10.1111/j.1742-4658.2007.05689.x.View ArticlePubMedGoogle Scholar
- Yeaman MR: Platelets in defense against bacterial pathogens. Cell Mol Life Sci. 2010, 67: 525-544. 10.1007/s00018-009-0210-4.View ArticlePubMedGoogle Scholar
- Ardehali B, Hand K, Nduka C, Holmes A, Wood S: Delayed leech-borne infection with Aeromonas hydrophilia in escharotic flap wound. J Plast Reconstr Aesthet Surg. 2006, 59: 94-95. 10.1016/j.bjps.2005.04.030.View ArticlePubMedGoogle Scholar
- Slesak G, Douangdala P, Inthalad S, Silisouk J, Vongsouvath M, Sengduangphachanh A, Moore CE, Mayxay M, Matsuoka H, Newton PN: Fatal Chromobacterium violaceum septicaemia in northern Laos, a modified oxidase test and post-mortem forensic family G6PD analysis. Ann Clin Microbiol Antimicrob. 2009, 8: 24-10.1186/1476-0711-8-24.View ArticlePubMedPubMed CentralGoogle Scholar
- Nehili M, Ilk C, Mehlhorn H, Ruhnau K, Dick W, Njayou M: Experiments on the possible role of leeches as vectors of animal and human pathogens: a light and electron microscopy study. Parasitol Res. 1994, 80: 277-290. 10.1007/BF02351867.View ArticlePubMedGoogle Scholar
- McGraw TA, Turiansky GW: Cutaneous myiasis. J Am Acad Dermatol. 2008, 58: 907-926. 10.1016/j.jaad.2008.03.014.View ArticlePubMedGoogle Scholar
- Dooley TA: The edge of tomorrow. . 1958, New York: Farrar, Straus & CudahyGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/11/14/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.